Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11730673.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To describe a 55-year-old male with Erdheim-Chester disease with bilateral orbital infiltration and visual loss who was successfully treated with interferon-alpha. Interventional case report. The patient was treated with interferon-alpha and had an improvement in his clinical signs, including his visual acuity, after 4 weeks of interferon therapy. Interferon-alpha can be effective in the treatment of orbital infiltration secondary to Erdheim-Chester disease.
Medical subject headings
- Granuloma
- Histiocytosis, Non-Langerhans-Cell
- Interferon-alpha
- Orbital Diseases
- Xanthomatosis